Hot Flash Treatments That Help Women Fail to Benefit Androgen-Deprived Men
December 20th 2013Men who experience hot flashes because they are undergoing androgen-deprivation therapy for prostate cancer are not significantly helped by two treatments that alleviate that symptom in menopausal women, the results of a study show.
Stemline Therapeutics Targets Capacity of Tumors to Adapt and Proliferate
December 17th 2013The investigational cancer medications being developed by Stemline Therapeutics attack only a tiny percentage of all tumor cells. But those few cells-the stem cells that resist most treatment and drive tumor growth-may just be the most important ones.
Burgeoning Field of Interventional Oncology Is Poised for Takeoff: A Q&A With Dan Brown, MD
December 5th 2013Interventional oncology is an emerging field in cancer care that is intended to complement existing treatment modalities. We sat down with Dan Brown, MD, the new chief of Interventional Oncology at Vanderbilt University Medical Center, to discuss the burgeoning field and its potential effect on cancer care moving forward.
Ramucirumab Improves Survival in Advanced Gastric Cancer
December 2nd 2013Ramucirumab, a monoclonal antibody that targets VEGFR-2, significantly prolonged survival in patients with advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma following progression on first-line therapy, according to results from the phase III REGARD study published in The Lancet.